The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2008, 181, 2483-2493
Copyright © 2008 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, H.
Right arrow Articles by Rostami, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, H.
Right arrow Articles by Rostami, A.

CD11c+CD11b+ Dendritic Cells Play an Important Role in Intravenous Tolerance and the Suppression of Experimental Autoimmune Encephalomyelitis1

Hongmei Li*, Guang-Xian Zhang*, Youhai Chen{dagger}, Hui Xu*, Denise C. Fitzgerald*, Zhao Zhao* and Abdolmohamad Rostami2,*

* Department of Neurology, Thomas Jefferson University, Philadelphia, PA 19107; and {dagger} Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19107

The central role of T cells in the induction of immunological tolerance against i.v. Ags has been well documented. However, the role of dendritic cells (DCs), the most potent APCs, in this process is not clear. In the present study, we addressed this issue by examining the involvement of two different DC subsets, CD11c+CD11b+ and CD11c+CD8+ DCs, in the induction of i.v. tolerance. We found that mice injected i.v. with an autoantigen peptide of myelin oligodendrocyte glycoprotein (MOG) developed less severe experimental autoimmune encephalomyelitis (EAE) following immunization with MOG peptide but presented with more CD11c+CD11b+ DCs in the CNS and spleen. Upon coculturing with T cells or LPS, these DCs exhibited immunoregulatory characteristics, including increased production of IL-10 and TGF-β but reduced IL-12 and NO; they were also capable of inhibiting the proliferation of MOG-specific T cells and enhancing the generation of Th2 cells and CD4+CD25+Foxp3+ regulatory T cells. Furthermore, these DCs significantly suppressed ongoing EAE upon adoptive transfer. These results indicate that CD11c+CD11b+ DCs, which are abundant in the CNS of tolerized animals, play a crucial role in i.v. tolerance and EAE and may be a candidate cell population for immunotherapy of autoimmune diseases.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by grants from the National Institutes of Health and the National Multiple Sclerosis Society.

2 Address correspondence and reprint requests to: A.M. Rostami, MD, PhD, Ste. 200 JHN, 900 Walnut St., Philadelphia, PA 19107. E-mail: a.m.rostami{at}jefferson.edu or Guang-Xian Zhang, MD, PhD, Ste. 300 JHN, 900 Walnut St., Philadelphia, PA 19107. E-mail: guang-xian.zhang{at}jefferson.edu

3 Abbreviations used in this paper: EAE, experimental autoimmune encephalomyelitis; MOG, myelin oligodendrocyte glycoprotein; MS, multiple sclerosis; DCs, dendritic cells; p.i. postimmunization; Treg cell, regulatory T cell; MNC, mononuclear cell; GA, glatiramer acetate.




This article has been cited by other articles:


Home page
J. Immunol.Home page
Q. Liu, C. Zhang, A. Sun, Y. Zheng, L. Wang, and X. Cao
Tumor-Educated CD11bhighIalow Regulatory Dendritic Cells Suppress T Cell Response through Arginase I
J. Immunol., May 15, 2009; 182(10): 6207 - 6216.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2008 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2008 by The American Association of Immunologists, Inc. All rights reserved.